Researcher
Aster Vandierendonck
- Keywords:Hepatocellular carcinoma
- Disciplines:Hepatology, Cancer biology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → 25 Sep 2022 - Department of Internal medicine (Department)
Member
From1 Oct 2016 → 30 Sep 2018
Projects
1 - 1 of 1
- Preclinical assessment of the therapeutic potential of multitargeting cancer stem cells through modulation of the unfolded protein response and deubiquitinases in hepatocellular carcinoma.From1 Oct 2016 → 30 Sep 2020Funding: BOF - Doctoral projects
Publications
1 - 10 of 11
- NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma(2021)
Authors: Aster Vandierendonck, Helena Degroote, Bart Vanderborght, Anja Geerts
- Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2020)
Authors: Sanne Van Campenhout, Laurentijn Tilleman, Sander Lefere, Aster Vandierendonck, Sarah Raevens, Xavier Verhelst, Anja Geerts, Filip Van Nieuwerburgh, Hans Van Vlierberghe, Lindsey Devisscher
- Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease(2019)
Authors: Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, et al.
Pages: 1087 - 1104 - Myeloid-specific IRE1 alpha deletion reduces tumour development in a non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2019)Volume: 70
Authors: Sanne Van Campenhout, Sander Lefere, Aster Vandierendonck, Anja Geerts
Pages: e380 - e381 - Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in non-alcoholic fatty liver disease(2018)Volume: 68
Authors: Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, et al.
Pages: 753A - 753A - The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma(2018)
Authors: Daniela Pollutri, Clarissa Patrizi, Sara Marinelli, Catia Giovannini, Elena Trombetta, Ferdinando A Giannone, Maurizio Baldassarre, Santina Quarta, Yves-Paul Vandewynckel, Aster Vandierendonck, et al.
- Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis(2018)Volume: 68
Authors: Sander Lefere, Frederique Van de Velde, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, S Neyt, Christian Vanhove, Anne Hoorens, Christophe Casteleyn, Bruno Lapauw, et al.
Pages: S329 - S329 - Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis(2018)Volume: 81
Authors: Sander Lefere, F Van de Velde, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Christian Vanhove, Anne Hoorens, CHRISTINE CASTELEYN, Bruno Lapauw, et al.
Number of pages: 1 - The unfolded protein response underlies microenvironmental stress-induced phenotype switching leading to stemness and chemoresistance in human hepatocellular carcinoma(2016)Volume: 64
Authors: Yves-Paul Vandewynckel, O Govaere, Aster Vandierendonck, Debby Laukens, Annelies Paridaens, Eliene Bogaerts, Sarah Raevens, Christophe Van Steenkiste, Louis Libbrecht, Christophe Ampe, et al.
Pages: S583 - S583 - Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma(2016)Volume: 64
Authors: Yves-Paul Vandewynckel, Céline Coucke, Debby Laukens, Annelies Paridaens, Eliene Bogaerts, Aster Vandierendonck, Sarah Raevens, Christophe Van Steenkiste, Louis Libbrecht, Anja Geerts
Pages: S583 - S583